Reporter: Amalia Nur Fitri
| Editor: Syamsul Azhar
LISTED COMPANY - JAKARTA. PT Prodia Widyahusada Tbk (PRDA) has announced a significant investment in the procurement of next-generation laboratory services with cobas® connection Modules, a cutting-edge information technology (IT) feature for clinical chemistry and immunoassay examinations.
PRDA's CEO, Dewi Muliaty, acknowledges that the expenditure is substantial. However, she assures that the spending aligns with their calculated projections.
Thanks for reading Kontan English.
Please create account or log in.
Only Rp5,000 to continue reading.
